###begin article-title 0
Epidermal Stem Cells Are Defined by Global Histone Modifications that Are Altered by Myc-Induced Differentiation
###end article-title 0
###begin p 1
Conceived and designed the experiments: MF FW. Performed the experiments: MF. Analyzed the data: MF. Contributed reagents/materials/analysis tools: AF. Wrote the paper: MF FW.
###end p 1
###begin p 2
Activation of Myc induces epidermal stem cells to exit their niche and differentiate into sebocytes and interfollicular epidermis, a process that is associated with widespread changes in gene transcription. We have identified chromatin modifications that are characteristic of epidermal stem cells and investigated the effects of Myc activation. Quiescent stem cells in the interfollicular epidermis and the hair follicle bulge had high levels of tri-methylated histone H3 at lysine 9 and H4 at lysine 20. Chromatin in both stem cell populations was hypoacteylated at histone H4 and lacked mono-methylation of histone H4 at lysine 20. Myc-induced exit from the stem cell niche correlated with increased acetylation at histone H4 and transiently increased mono-methylation at lysine 20. The latter was replaced by epigenetic modifications that are largely associated with chromatin silencing: di-methylation at histone H3 lysine 9 and histone H4 lysine 20. These modifications correlated with changes in the specific histone methyltransferases Set8 and Ash-1. The Myc-induced switch from mono- to di-methylated H4K20 required HDAC activity and was blocked by the HDAC inhibitor trichostatin A (TSA). TSA treatment induced a similar epidermal phenotype to activation of Myc, and activation of Myc in the presence of TSA resulted in massive stimulation of terminal differentiation. We conclude that Myc-induced chromatin modifications play a major role in Myc-induced exit from the stem cell compartment.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 176 179 176 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Jenuwein1">[1]</xref>
###xml 181 184 181 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Lund1">[2]</xref>
###xml 449 452 449 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Lund1">[2]</xref>
###xml 570 573 570 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Hsieh1">[3]</xref>
Many histone modifications, including acetylation, phosphorylation, ubiquitination, sumoylation, and methylation, are known to regulate chromatin structure and gene expression [1], [2]. This is illustrated by modification of histone H3. When a gene is transcriptionally active histone H3 is acetylated at lysines 9 and 14 and di- or tri-methylated at lysine 4. Conversely, in inactive chromatin histone H3 is di- or tri-methylated at lysine 9 or 27 [2]. Epigenetic modifications are set by cell-type specific transcriptional regulators and chromatin remodelling enzymes [3].
###end p 4
###begin p 5
###xml 273 276 273 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Xi1">[4]</xref>
###xml 405 408 405 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Kondo1">[5]</xref>
###xml 521 524 521 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Baxter1">[6]</xref>
###xml 634 637 634 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Kubicek1">[7]</xref>
###xml 137 147 <span type="species:ncbi:7227">Drosophila</span>
There is growing evidence that specific chromatin modifications distinguish stem and differentiated cells in a wide range of tissues. In Drosophila, germ line and somatic stem cell self-renewal are controlled by the chromatin remodelling factors ISWI and DOM, respectively [4]. In neural stem cells epigenetic marks are believed to be the main intrinsic factor regulating self-renewal and differentiation [5]. In the haematopoietic system quiescent B lymphocytes are characterised by global hypomethylation at histone H3 [6]. Under-representation of repressive histone marks could be indicative of epigenetic plasticity in stem cells [7].
###end p 5
###begin p 6
###xml 338 341 338 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Cotsarelis1">[8]</xref>
###xml 343 346 343 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Jensen1">[9]</xref>
###xml 348 352 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Watt1">[10]</xref>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Arnold1">[11]</xref>
###xml 564 568 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Waikel1">[12]</xref>
###xml 655 659 655 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Patel1">[13]</xref>
###xml 661 665 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Dang1">[14]</xref>
###xml 771 775 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Frye1">[15]</xref>
###xml 777 781 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Frye2">[16]</xref>
###xml 783 787 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Gebhardt1">[17]</xref>
###xml 921 925 921 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Cowling1">[18]</xref>
###xml 1004 1008 1004 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Knoepfler1">[19]</xref>
###xml 285 290 <span type="species:ncbi:9606">human</span>
Mammalian epidermis provides an excellent model in which to analyse the state and significance of chromatin modifications in stem cells and their progeny. There are two reasons for this. The first is that the location of at least two stem cell pools, in the hair follicle bulge and in human interfollicular epidermis, is well established [8], [9], [10]. The second is that activation of the transcription factor Myc triggers exit from the epidermal stem cell compartment and induces differentiation along the sebaceous and interfollicular epidermal lineages [11], [12]. Recent studies suggest that Myc acts as a widespread regulator of gene transcription [13], [14], and both activation and repression of gene expression contribute to the Myc-induced epidermal phenotype [15], [16], [17]. The biochemical mechanism of Myc-mediated transactivation has revealed a wide range of effects on chromatin and basal transcription [18]. Myc proteins are required for the widespread maintenance of active chromatin [19].We therefore set out to investigate whether adult epidermal stem cells have common epigenetic modifications and how these change in response to Myc activation.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 17 22 <span type="species:ncbi:9606">human</span>
Histone marks in human epidermis
###end title 8
###begin p 9
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Jensen1">[9]</xref>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Legg1">[20]</xref>
###xml 349 357 349 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g001">Figure 1</xref>
###xml 48 53 <span type="species:ncbi:9606">human</span>
We began by investigating whether stem cells in human interfollicular epidermis were characterised by specific histone modifications. We prepared epidermal whole mounts [9], [20] and labelled them with antibodies specific for histone H3 methylation at lysines 4 (H3diK4) or 9 (H3diK9, H3triK9) and an antibody that detects acetylation of H4 (H4Ac) (Figure 1).
###end p 9
###begin title 10
###xml 40 45 <span type="species:ncbi:9606">human</span>
Histone modifications in basal layer of human interfollicular epidermis.
###end title 10
###begin p 11
Double label immunofluorescence staining of whole mounts with antibodies to ss1 integrins (red) and (green) H3diK4 (A-C), H3diK9 (D-F), H3triK9 (G-I) and H4Ac (J-L), with DAPI nuclear counterstain (blue). C, F, I, L show merged images (left hand panels) and higher magnification views (right hand panels). Scale bars: 20 microm.
###end p 11
###begin p 12
###xml 474 483 469 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g001">Fig. 1A&#8211;I</xref>
###xml 583 592 577 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g001">Fig. 1J&#8211;L</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 650 655 <span type="species:ncbi:9606">human</span>
Human interfollicular epidermal stem cells express high levels of ss1 integrins and are arranged in clusters in the epidermal basal layer, surrounded by their progeny, transit amplifying (TA) cells, and cells that have initiated terminal differentiation. Double labelling for beta1 integrins and antibodies to modified histones revealed that although levels of H3diK4 or H3di, triK9 methylation varied, there was no correlation with high or low expression of ss1 integrins (Fig. 1A-I). In contrast, cells that expressed high levels of ss1 integrins had low levels of H4 acetylation (Fig. 1J-L). Therefore low levels of H4 acetylation are a marker of human interfollicular epidermal stem cells.
###end p 12
###begin title 13
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
Histone marks in the mouse hair follicle bulge
###end title 13
###begin p 14
###xml 157 160 157 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Cotsarelis1">[8]</xref>
###xml 344 348 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Bickenbach1">[21]</xref>
###xml 350 354 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Braun1">[22]</xref>
###xml 485 494 485 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g002">Fig. 2A&#8211;F</xref>
###xml 496 500 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Braun1">[22]</xref>
###xml 694 703 694 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g002">Fig. 2A&#8211;C</xref>
###xml 857 866 857 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g002">Fig. 2D&#8211;F</xref>
###xml 868 875 868 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000763.s001">Fig. S1</xref>
###xml 3 8 <span type="species:ncbi:10090">mouse</span>
###xml 463 468 <span type="species:ncbi:10090">mouse</span>
In mouse epidermis the best characterised pool of stem cells is not in the interfollicular epidermis but in a region of the hair follicle known as the bulge [8]. One characteristic of bulge stem cells is that if they incorporate BrdU in neonatal epidermis they retain the label in adulthood; such cells are known as label retaining cells (LRC) [21], [22]. We therefore examined the state of histone modifications in label retaining cells (LRC) in whole mounts of mouse tail epidermis (Fig. 2A-F) [22]. Antibodies to H3diK4, H3diK9 and H3triK9 gave uniform labelling along the outer root sheath (ORS) of the hair follicle, and most LRC, like the rest of the bulge cells, were strongly labelled (Fig. 2A-C; line; insert). To quantify these results we counted the total number of LRC per bulge and scored each cell as strongly (high) or weakly (low) labelled (Fig. 2D-F, Fig. S1).
###end p 14
###begin title 15
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
Variation in histone H3 methylation in mouse epidermis and effects of Myc activation.
###end title 15
###begin p 16
###xml 504 511 502 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000763.s001">Fig. S1</xref>
Immunofluorescence staining for LRC (red) and (green) H3diK4 (A, G, J), H3diK9 (B, H, K) and H3triK9 (C, I, L) in whole mounts of wild type (A-C, G-I) and 4OHT treated K14MycER (J-L) epidermis. Position of hair follicle bulge is marked by line in A-C. Inserts in A-C show higher magnification views of bulge LRC. G-L show LRC in interfollicular epidermis. (D-F, M-O) Quantitation (+/-S.D.) of number of LRC per bulge (D-F) and interfollicular epidermis (M-O) that had high or low levels of staining (see Fig. S1) with antibodies to the H3 modifications indicated. Scale bars: 100 microm (A-C), 20 microm (G-L).
###end p 16
###begin p 17
###xml 157 168 157 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g002">Figure 2G&#8211;I</xref>
###xml 286 292 286 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g002">Fig. 2</xref>
###xml 328 337 328 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g002">Fig. 2I,O</xref>
Whereas levels of histone methylation appeared to be uniform in bulge cells, we detected heterogeneity amongst cells of the interfollicular epidermis (IFE) (Figure 2G-I). The majority of BrdU positive LRC in wild-type interfollicular epidermis were low in H3diK4 or H3diK9 methylation (Fig. 2 G,H and M,N), but high in H3triK9 (Fig. 2I,O).
###end p 17
###begin p 18
We conclude that LRC in the bulge and the IFE represent distinct cell populations when characterised by the level of H3 methylation.
###end p 18
###begin title 19
Effect of Myc activation on epidermal histone marks
###end title 19
###begin p 20
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Gandarillas1">[23]</xref>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Arnold1">[11]</xref>
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Waikel1">[12]</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Frye1">[15]</xref>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Gebhardt1">[17]</xref>
###xml 849 853 849 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Arnold1">[11]</xref>
###xml 855 859 855 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Waikel1">[12]</xref>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
Epidermal stem cells can be stimulated to exit the stem cell compartment by activation of the transcription factor Myc [23]. In response to Myc, stem cells move into the TA compartment, where they undergo several rounds of division and then differentiate along the lineages of the interfollicular epidermis and sebaceous gland [11], [12], [15], [17]. To investigate the consequences of overexpressing Myc on histone modifications in epidermal cells, we prepared whole mounts of tail epidermis from K14MycER mice that had been treated with 4-hydroxy-tamoxifen (4OHT). The keratin 14 promoter drives transgene expression in stem and transit amplifying cells in all regions of the epidermis. MycER is a chimeric protein in which the C-terminus of Myc is fused to a mutant oestrogen receptor; thus Myc is only activated when cells are treated with 4OHT [11], [12].
###end p 20
###begin p 21
###xml 23 27 23 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Braun1">[22]</xref>
###xml 112 126 112 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g002">Fig. 2D&#8211;F, M&#8211;O</xref>
###xml 282 291 282 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g002">Fig. 2D&#8211;F</xref>
###xml 431 440 431 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g002">Fig. 2M,N</xref>
###xml 560 569 560 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g002">Fig. 2M,N</xref>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
As reported previously [22], activation of Myc did not alter the number or location of LRC in the bulge or IFE (Fig. 2D-F, M-O and data not shown). In the bulge, the level of methylation of H3diK4 and H3di, triK9 was similar in 4OHT treated K14MycER mice and wild-type littermates (Fig. 2D-F). However, the IFE differed from the bulge in its response to Myc. We still detected LRC with low levels of H3diK4 and H3diK9 methylation (Fig. 2M,N), but the proportion of cells with high levels of these modifications was increased compared to wild-type control LRC (Fig. 2M,N).
###end p 21
###begin p 22
###xml 226 233 226 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g002">Fig. 2O</xref>
The most dramatic effect of Myc was on H3triK9 methylation of interfollicular epidermal LRC. The majority of LRC in Myc activated epidermis were low in H3triK9 methylation, whereas in controls most of the LRC had high levels (Fig. 2O). This suggests that Myc increased H3diK9 methylation at expense of H3triK9 methylation.
###end p 22
###begin title 23
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
Low levels of H4 acetylation are a mark of label retaining cells in mouse epidermis that is regulated by Myc
###end title 23
###begin p 24
###xml 86 92 86 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g001">Fig. 1</xref>
###xml 158 167 158 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g003">Fig. 3A&#8211;D</xref>
###xml 268 277 268 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g003">Fig. 3A,B</xref>
###xml 434 443 434 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g003">Fig. 3C,D</xref>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 141 146 <span type="species:ncbi:10090">mouse</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 474 479 <span type="species:ncbi:9606">human</span>
###xml 484 489 <span type="species:ncbi:10090">mouse</span>
###xml 527 532 <span type="species:ncbi:10090">mouse</span>
Since low H4 acetylation was common in stem cells in human interfollicular epidermis (Fig. 1), we examined whether this was also the case in mouse epidermis (Fig. 3A-D). The entire bulge had much lower levels of histone acetylation than the rest of the hair follicle (Fig. 3A,B; Bg). Double labelling for BrdU and H4Ac demonstrated that LRC in both the bulge and interfollicular epidermis of wild-type mice had low acetylation of H4 (Fig. 3C,D; insert). We conclude that in human and mouse interfollicular epidermis and in the mouse hair follicle bulge, stem cells are characterised by low levels of histone H4 acetylation.
###end p 24
###begin title 25
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Variation in histone H4 acetylation and methylation in mouse epidermis and effects of Myc activation.
###end title 25
###begin p 26
(A-C, E-G, I-K) Immunofluorescence staining of whole mounts of wild-type (A-C, F, G, K) and 4OHT treated K14MycER transgenic (E,I, J) epidermis with antibodies to (green) H4Ac (A-C, E), H4monoK20 (F, G, I, J) and H4triK20 (K). Double labelling for LRC (red) is shown in C, G, I, K. I and inserts in C, G, K show high magnification views of LRC. IFE: interfollicular epidermis; sebaceous gland (SG), bulge (Bg), bulb (Bb) are marked with arrows in A, E. Hair follicles and sebaceous glands are marked with dashed lines in A, B, E, F, J; LRC are marked with dashed lines in C, G, I, K; position of bulge is marked with line in C, G, K. D, H, L show quantitation (+/-S.D.) of number of LRC per bulge with high or low levels of the H4 modifications indicated. M-R: immunofluorescence labelling (green) with DAPI counterstain (blue) of wild-type (M-O) and 4OHT treated K14MycER (P-R) dorsal interfollicular epidermis using antibodies to H4monoK20 (M, P), H4diK20 (N, Q) and keratin 10 (O, R). Dashed lines indicate position of basement membrane. Scale bar: 50 microm
###end p 26
###begin p 27
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Knoepfler1">[19]</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Frank1">[24]</xref>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-McMahon1">[25]</xref>
###xml 400 407 400 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g003">Fig. 3D</xref>
###xml 518 527 518 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g003">Fig. 3A,E</xref>
###xml 603 612 603 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g003">Fig. 3A,E</xref>
Acetylation of histone H3 and H4 is a chromatin modification known to be mechanistically associated to Myc-induced transactivation. Myc regulates gene transcription by recruiting the histone acetyltransferases GCN5 and TIP60, and by directly up-regulating GCN5 [19], [24], [25]. Therefore it was not surprising that in 4OHT treated K14MycER epidermis there was increased H4 acetylation of bulge LRC (Fig. 3D). Indeed, on activation of Myc the bulge could no longer be distinguished on the basis of low H4 acetylation (Fig. 3A,E; Bg), and acetylation was also increased in the interfollicular epidermis (Fig. 3A,E; IFE).
###end p 27
###begin p 28
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Talasz1">[26]</xref>
###xml 465 471 465 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g003">Fig. 3</xref>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
We next asked whether H4 acetylation was correlated with methylation at lysine 20 (K20). Mono-methylation of histone H4 at lysine 20 (H4monoK20) is increased in the promoter and coding regions of active genes and correlates with histone hyperacetylation [26]. In the epidermis of wild-type mice, levels of H4monoK20 correlated with acetylation of H4, being low in the bulge (Bg) and high in other regions of the epidermis, particularly the hair follicle bulb (Bb) (Fig. 3 B,F).
###end p 28
###begin p 29
###xml 154 163 154 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g003">Fig. 3G&#8211;I</xref>
###xml 249 256 249 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g003">Fig. 3J</xref>
###xml 503 512 503 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g003">Fig. 3K,L</xref>
The increase in H4 acetylation resulting from activation of Myc correlated with increased levels of H4monoK20 in bulge and interfollicular epidermal LRC (Fig. 3G-I). However, the increase was modest and did not occur throughout the whole epidermis (Fig. 3J), leading us to speculate that H4monoK20 might accumulate only transiently and be replaced with another modification, such as H4di- or triK20. Since the number of LRC with high levels of H4triK20 was decreased in 4OHT treated K14MycER epidermis (Fig. 3K,L), we speculated that H4monoK20 might be replaced by H4diK20.
###end p 29
###begin title 30
Myc-induced switch from H4monoK20 to H4diK20 depends on HDAC activity
###end title 30
###begin p 31
###xml 201 210 201 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g003">Fig. 3N,Q</xref>
###xml 323 332 323 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g003">Fig. 3M,P</xref>
###xml 461 470 461 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g003">Fig. 3N&#8211;R</xref>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 306 321 <span type="species:ncbi:10090">transgenic mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
To demonstrate that H4diK20 was up-regulated in vivo, we treated K14MycER and wild-type control mice for 6 days with 4OHT. H4diK20 was dramatically increased in K14MycER mice compared to the controls (Fig. 3N,Q). Whereas nuclei high in H4monoK20 were localised to the basal layer of the IFE in control and transgenic mice (Fig. 3M,P), cells with high levels of H4diK20 were found in the differentiating, keratin 10 positive, suprabasal layers of K14MycER mice (Fig. 3N-R).
###end p 31
###begin p 32
###xml 101 105 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Terranova1">[27]</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Yoshida1">[28]</xref>
###xml 383 392 383 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g004">Fig. 4A,B</xref>
###xml 474 483 474 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g004">Fig. 4C,D</xref>
###xml 255 260 <span type="species:ncbi:10090">mouse</span>
The re-organisation of constitutive heterochromatin from H4monoK20 to H4diK20 requires HDAC activity [27]. If Myc replaces H4monoK20 with H4diK20, the process should be blocked with the HDAC inhibitor, trichostatin A (TSA) [28]. When we treated wild-type mouse epidermis with TSA, increased numbers of cells with H4monoK20 were found in the IFE, hair follicles and sebaceous glands (Fig. 4A,B). The effect was even more pronounced when TSA was combined with Myc activation (Fig. 4C,D).
###end p 32
###begin title 33
Effects of TSA treatment and Myc activation on histone H4 modification.
###end title 33
###begin p 34
###xml 370 375 <span type="species:ncbi:9606">human</span>
(A-D) whole mounts of wild-type (A, B) and K14MycER (C, D) epidermis treated with 4OHT alone (A, C) or in combination with TSA (B, D), labelled with antibody to H4monoK20 (green) and counterstained with DAPI (blue). Hair follicles and sebaceous glands (SG) are outlined with dashed lines. Bg: bulge; Bb: bulb (A-D). (E-P) Double immunofluorescence labelling of cultured human keratinocytes transduced with empty vector (k-pBabe; E, F, I, J, M, N) or MycER (k-MycER; G, H, K, L, O, P) and treated for 24 h with 4OHT alone (E, I, M, G, K, O) or 4OHT+TSA (F, J, N, H, L, P). Cells were stained with antibodies to H4monoK20 (red) and H4diK20 (green) with DAPI counterstain (blue). E-H are merged images of the panels below. (Q,R) Quantitation (+/-S.D.) of % cells per colony with high levels of H4monoK20 (Q) or H4diK20 (R). Cells were stimulated with 4OHT alone (4OHT) or 4OHT and TSA (TSA). P values (t-test) are *0.0046, **0.0505 (Q) and *0.0545, **0.0211, ***0.0192 (R). Scale bar: 100 microm (A-D), 20 microm (E-P).
###end p 34
###begin p 35
###xml 271 280 271 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g004">Fig. 4E&#8211;P</xref>
###xml 384 395 384 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g004">Fig. 4I,K,R</xref>
###xml 435 446 435 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g004">Fig. 4K,L,R</xref>
###xml 540 549 540 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g004">Fig. 4M&#8211;Q</xref>
###xml 101 106 <span type="species:ncbi:9606">human</span>
To examine the mechanism by which Myc induced the switch from H4monoK20 to H4diK20, cultured primary human keratinocytes transduced with a MycER retroviral vector or an empty vector control (pBabe) were labelled with antibodies to the different states of H4 methylation (Fig. 4E-P). The number of cells with high levels of H4diK20 increased by approximately 25% on activation of Myc (Fig. 4I,K,R), an effect that was inhibited by TSA (Fig. 4K,L,R). In both pBabe and Myc expressing keratinocytes, H4monoK20 increased on treatment with TSA (Fig. 4M-Q).
###end p 35
###begin p 36
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Fang1">[29]</xref>
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Xiao1">[30]</xref>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Beisel1">[31]</xref>
###xml 411 418 411 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g005">Fig. 5A</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Frye2">[16]</xref>
###xml 602 609 602 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g005">Fig. 5A</xref>
Replacement of H4monoK20 with H4diK20 in response to Myc activation should be accompanied by activation of specific histone methyltransferases. Set8 is an H4K20 specific mono-methylase [29], [30], while H4K20 di-methylation is dependent on the histone methyltransferase Ash-1 [31]. Western blotting showed that expression of Set8 was transiently up-regulated within 12 hours of activating Myc in keratinocytes (Fig. 5A; left hand panel). Induction of the RNA methyltransferase Misu (NSun2), a direct down-stream target of Myc [16], served as a positive control for Myc activation in the Western blots (Fig. 5A; left hand panel).
###end p 36
###begin title 37
Expression of histone methyl transferases in response to Myc and TSA.
###end title 37
###begin p 38
(A) Western blots of keratinocytes infected with empty vector (K-pBabe) or MycER (K-MycER) and treated with 4OHT+/-TSA for the number of hours indicated. Blots were probed with antibodies to the proteins indicated. Tubulin (Tub) was used as a loading control. (B) Immunostaining for Ash-1 (red) with DAPI counterstain (blue). Scale bar: 10 microm.
###end p 38
###begin p 39
###xml 184 191 184 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g005">Fig. 5A</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Frye2">[16]</xref>
###xml 441 448 441 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g005">Fig. 5A</xref>
###xml 616 623 616 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g005">Fig. 5B</xref>
TSA treatment had different effects on control keratinocytes and keratinocytes with activated Myc. In control cells transduced with pBabe, TSA caused a transient upregulation of Set8 (Fig. 5A; right hand panel), which may reflect an initial increase in S phase cells (detected as elevated Misu expression), followed by arrest in G2+M of the cell cycle [16]. In TSA treated cells with activated Myc, Set8 was highly expressed at 12 and 24 h (Fig. 5A; right hand panel). The effect of activation of Myc on Ash-1 was to stimulate nuclear accumulation, a process that was inhibited when the cells were treated with TSA (Fig. 5B).
###end p 39
###begin title 40
Inhibition of HDACs has similar effects on the epidermal stem cell compartment to activation of Myc
###end title 40
###begin p 41
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Arnold1">[11]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Gandarillas1">[23]</xref>
###xml 610 627 610 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g006">Fig. 6A&#8211;C and E&#8211;G</xref>
###xml 675 684 675 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g006">Fig. 6E&#8211;G</xref>
###xml 747 756 747 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g006">Fig. 6Q,R</xref>
###xml 926 940 926 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g006">Fig. 6I&#8211;K, M&#8211;O</xref>
###xml 346 351 <span type="species:ncbi:10090">mouse</span>
Our results show that acetylation of H4 and mono-methylation of H4 at lysine 20 are low in epidermal stem cells, and that activation of Myc or treatment with TSA increases both modifications. If the modifications contribute to the mechanism of Myc-induced exit from the epidermal stem cell compartment [11], [23], then TSA treatment of wild-type mouse epidermis should result in a similar phenotype to Myc activation. Indeed we found that both TSA treatment of wild-type epidermis and 4OHT treatment of K14MycER epidermis led to a marked increase in the number of cell layers in the interfollicular epidermis (Fig. 6A-C and E-G; arrows), enlargement of the sebaceous glands (Fig. 6E-G; arrowheads and Q-S) and expansion of the hair follicle bulb (Fig. 6Q,R). TSA treatment, like Myc activation, led to an increase in proliferation, as measured by Ki67 labelling and incorporation of a 1 hour pulse of BrDU into S phase cells (Fig. 6I-K, M-O; arrowheads).
###end p 41
###begin title 42
TSA treatment induces similar changes in epidermal proliferation and differentiation to activation of Myc, and exacerbates the effects of Myc.
###end title 42
###begin p 43
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Wild-type (A, B, E, F, I, J, M, N, Q, R) and K14MycER transgenic (C, D, G, H, K, L, O, P, S, T) mice were treated with 4OHT alone (A, C, E, G, I, K, M, O, Q, S) or in combination with TSA (B, D, F, H, J, L, N, P, R, T). 4OHT treatment of wild-type epidermis served as a negative control. A-P are sections of back skin; Q-T are whole mounts of tail skin. Sections were stained with haematoxylin and eosin (A-H), anti-BrdU (brown, I-L) or anti Ki67 (brown, M-P). Whole mounts were stained for keratin 14 (green) with DAPI counterstain (blue). Arrows in B, C, F, G, H show thickening of interfollicular epidermis. Arrow in D shows detachment of epidermis from dermis. Arrowhead in F shows enlarged sebaceous gland. Arrowheads in J-L, N-P show different numbers of proliferating cells. SG: sebaceous glands. Scale bars: 100 microm
###end p 43
###begin p 44
###xml 90 105 90 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g006">Fig. 6D,H,L,P,T</xref>
###xml 170 177 170 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g006">Fig. 6D</xref>
###xml 287 294 287 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g006">Fig. 6D</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Frye2">[16]</xref>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Gandarillas1">[23]</xref>
###xml 578 587 578 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g006">Fig. 6L,P</xref>
###xml 611 620 611 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g006">Fig. 6K,O</xref>
###xml 809 816 809 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g006">Fig. 6H</xref>
###xml 875 882 875 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g006">Fig. 6T</xref>
Activation of Myc in the presence of TSA exacerbated the phenotype of K14MycER epidermis (Fig. 6D,H,L,P,T). There was massive accumulation of cornified cells in the IFE (Fig. 6D); in some areas no viable cell layers remained and the epidermis began to detach from the underlying dermis (Fig. 6D; arrow). Both TSA and Myc cause arrest of cultured keratinocytes in G2/M-phase of the cell cycle, prior to initiation of terminal differentiation [16], [23]. Consistent with these findings, the number of proliferative cells was lower in K14MycER epidermis treated with 4OHT and TSA (Fig. 6L,P) than with 4OHT alone (Fig. 6K,O). In addition to the effects on the interfollicular epidermis, the combination of TSA treatment and Myc activation resulted in further increases in the number of differentiated sebocytes (Fig. 6H; arrowhead and 6T) and aberrant hair follicle morphology (Fig. 6T).
###end p 44
###begin p 45
We conclude that Myc-induced chromatin modifications play a major role in Myc-induced exit from the stem cell compartment and differentiation into interfollicular epidermis and sebocytes.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 244 250 244 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g007">Fig. 7</xref>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Owens1">[32]</xref>
###xml 609 613 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Ito1">[33]</xref>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Levy1">[34]</xref>
We have demonstrated that quiescent epidermal stem cells in both the interfollicular epidermis and the hair follicle are characterised by high levels of tri-methylated H3K9 and H4K20 and low levels of H4 acetylation and H4K20 mono-methylation (Fig. 7). We observed that whereas bulge LRC had high levels of di-methylated H3K9 and H3K4, LRC in the IFE did not. While we do not have a functional explanation for this difference, it is consistent with reports of differences in the properties of stem cells in the bulge and IFE and may reflect differences in sensitivity to intrinsic and extrinsic factors [32], [33], [34].
###end p 47
###begin title 48
Model of histone modifications in different epidermal compartments and effect of Myc activation.
###end title 48
###begin p 49
Red arrows indicate events stimulated by Myc. Stem cells and terminally differentiated cells are shown as having high levels of histone tri-methylation and low levels of histone acetylation, mono- and di-methylation. Myc increases global H4 acetylation and transient mono-methylation of H4K20, which is replaced di-methylation of H4K20, H3K4 and H3K9 at the expense of tri-methylation. HAT: histone acetyl transferase; HDAC: histone deacetyl transferase complex.
###end p 49
###begin p 50
###xml 110 113 110 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Baxter1">[6]</xref>
###xml 115 118 115 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Kubicek1">[7]</xref>
###xml 503 507 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Sparmann1">[35]</xref>
###xml 778 782 778 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Watt1">[10]</xref>
###xml 1062 1068 1062 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g007">Fig. 7</xref>
###xml 1133 1137 1133 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Watt1">[10]</xref>
In other cell types epigenetic plasticity is associated with under-representation of repressive histone marks [6], [7]. Epidermal stem cells, however, had high levels of histone H3triK9 and H4triK20, indicating that large sets of genes are repressed by Polycomb group (PcG) complexes. In embryonic stem cells, PcG proteins regulate stem cell pluripotency by maintaining repression of alternative lineage genes that are necessary for differentiation of stem or progenitor cells into various tissue types [35]. A similar situation might exist in adult epidermis. Although epidermal stem cells have the capacity to differentiate along multiple lineages, in undamaged, steady-state epidermis they appear to be specified to differentiate along only one or a small number of lineages [10]. This would be consistent with our observation that the terminally differentiated cells in the epidermis are, like stem cells, rich in H3K9 and H4K20 trimethylation. It also raises the interesting possibility that transit amplifying cells, being low in repressive histone marks (Fig. 7), are more susceptible to lineage reprogramming than stem cells [10].
###end p 50
###begin p 51
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Arnold1">[11]</xref>
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Waikel1">[12]</xref>
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Gandarillas1">[23]</xref>
###xml 404 410 404 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g007">Fig. 7</xref>
###xml 646 650 646 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Knoepfler1">[19]</xref>
###xml 652 656 652 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Fernandez1">[36]</xref>
###xml 672 675 672 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 876 880 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Knoepfler1">[19]</xref>
In response to Myc activation epidermal stem cells enter the transit amplifying compartment, leading to a transient increase in proliferation followed by exit from the cell cycle and initiation of differentiation [11], [12], [23]. Exit from the stem cell niche is correlated with global histone H4 hyperacetylation, and transient histone H4 monomethylation at lysine 20 followed by stable dimethylation (Fig. 7). The increase in global histone H4 acetylation in response to Myc is in line with previous observations. Histone acetylation is known to be enhanced by Myc and is, at least in part, mediated by the direct up-regulation of GCN5 by Myc [19], [36]. Deletion of N-myc in neural progenitor cells leads to chromatin changes associated with chromatin inactivation, such as histone H3 and H4 hypoacetylation and increased di- and tri-methylation at histone H3 at lysine 9 [19].
###end p 51
###begin p 52
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Fernandez1">[36]</xref>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Fernandez1">[36]</xref>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Frank2">[37]</xref>
###xml 348 352 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-ONeill1">[38]</xref>
Myc has the highest affinity for target genes in open, preacetylated chromatin and further enhances histone acetylation [36]. However, Myc binding and acetylation do not systematically correlate with gene activation [36], [37]. H4 acetylation is also reported to distinguish coding regions from heterochromatin independent of transcriptional state [38]. Myc-induced hyperacetylation may therefore represent a global epigenetic mark for coding regions that facilitates the binding of transcription factors required for subsequent positive or negative regulation of gene expression.
###end p 52
###begin p 53
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Talasz1">[26]</xref>
###xml 342 348 342 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g007">Fig. 7</xref>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Knoepfler1">[19]</xref>
###xml 813 817 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Fang1">[29]</xref>
###xml 819 823 819 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Xiao1">[30]</xref>
Although hyperacetylation of histone H4 has been found to correlate with mono-methylation at lysine 20 in promoter and coding regions of active genes [26], Myc-induced hyperacetylation correlated with only a transient increase in mono-methylation and with stable accumulation of nuclei with high levels of di-methylated H4K20, H3K4 and H3K9 (Fig. 7). In contrast to our observation that di-methylation increased in response to Myc, high levels of H3diK9 and H3triK9 are also found in N-myc null neural progenitors [19]. These results might indicate that di-methylation, at least at H3K9, is not directly regulated by Myc or involves additional factors. Nevertheless, the increased di-methylation in response to Myc in skin correlated with expression of the corresponding histone methyltransferases Set8 and Ash-1 [29], [30].
###end p 53
###begin p 54
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Sims1">[39]</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Guccione1">[40]</xref>
Our finding that di-methylation at different histones was partitioned together might be a general mechanism of regulating chromatin structures. Mono-methylated H4 at lysine 20 and H3 lysine 9 are partitioned together, as are the di-methylated forms, whereas mono- and di-methylated forms are virtually mutually exclusive [39]. In addition, chromatin marks that are associated with highly active promoters partition together and allow high affinity binding of transcription factors like Myc [40].
###end p 54
###begin p 55
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Arnold1">[11]</xref>
###xml 426 430 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Markova1">[41]</xref>
Histone acetylation can either be induced by Myc activation or by inhibiting deacetylation via TSA. TSA treatment also led to a major increase in the levels of H4monoK20 in the epidermis. The strikingly similar effects of Myc and TSA in stimulating proliferation followed by differentiation strongly suggest that histone hyperacetylation is part of the mechanism by which keratinocytes initiate terminal differentiation [11], [41].
###end p 55
###begin p 56
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Konstantinopoulos1">[42]</xref>
HDAC inhibitors are currently in clinical trials for various types of cancer. These drugs can potentially reverse the resistance of tumour cells to traditional chemotherapeutic drugs [42]. Our observations suggest that, in addition, HDAC inhibitors could be beneficial because they promote differentiation. However, by mobilizing stem cells to leave the niche the drugs could also have the undesirable effect of compromising epithelial homeostasis in healthy tissues.
###end p 56
###begin p 57
###xml 472 487 <span type="species:ncbi:10090">transgenic mice</span>
Our data suggest that activation of Myc induces a widespread change in chromatin state that is permissive for transcription factor binding. In response to activated Myc chromatin modifications that are associated with both chromatin silencing and gene activation were increased. This indicates that Myc induces an intermediate state of facultative heterochromatin and might delay the formation of obligate heterochromatin. This would explain why the epidermis of K14MycER transgenic mice displays both hyperproliferation and increased terminal differentiation. It would also explain how a single transcription factor can exert such broad pro-differentiative and pro-tumorigenic effects.
###end p 57
###begin title 58
Materials and Methods
###end title 58
###begin title 59
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
Transgenic mice and treatment
###end title 59
###begin p 60
###xml 35 39 35 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Arnold1">[11]</xref>
###xml 9 24 <span type="species:ncbi:10090">transgenic mice</span>
###xml 146 151 <span type="species:ncbi:10090">mouse</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 421 426 <span type="species:ncbi:10090">Mouse</span>
K14MycER transgenic mice (2184C.1) [11] and nontransgenic littermates (wild-type controls) received topical applications of 4OHT (Sigma, 1 mg per mouse per day) or trichostatin A (TSA) (Sigma, 1mg per kg per day) to a shaved area of dorsal skin. 4OHT and TSA were dissolved in ethanol. When mice were treated with both 4OHT and TSA, the animals received 4OHT or TSA on alternate days over the treatment period of 6 days. Mouse breeding and experimental protocols were subject to Institutional ethical approval and were performed under the terms of a U.K. Government Home Office licence.
###end p 60
###begin title 61
BrdU labelling
###end title 61
###begin p 62
###xml 231 235 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Braun1">[22]</xref>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
To generate label-retaining cells (LRC), 10-day-old mice were injected with 50 mg/kg (body weight) 5-bromo-2'-deoxyuridine (BrdU; 20 microl of 12.5 mg/ml BrdU) every 12 hours for a total of four injections, as described previously [22]. In some experiments mice were injected with BrDU one hour prior to sacrifice, in order to label S phase cells.
###end p 62
###begin title 63
Tissue preparation
###end title 63
###begin p 64
###xml 159 163 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Braun1">[22]</xref>
###xml 185 188 181 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Jensen1">[9]</xref>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
###xml 143 148 <span type="species:ncbi:10090">mouse</span>
###xml 174 179 <span type="species:ncbi:9606">human</span>
###xml 228 233 <span type="species:ncbi:9606">Human</span>
Frozen sections (5-7 microm) of mouse dorsal and tail skin were fixed for 10 minutes in 4% paraformaldehyde prior to labelling. Wholemounts of mouse tail skin [22] and adult human skin [9] were prepared as described previously. Human skin was obtained as surgical waste from mastectomy operations with appropriate ethical approval.
###end p 64
###begin title 65
Immunostaining and image analysis
###end title 65
###begin p 66
###xml 53 57 53 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Frye1">[15]</xref>
###xml 59 63 59 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Frye2">[16]</xref>
###xml 261 265 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Dittel1">[43]</xref>
###xml 430 434 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Frye2">[16]</xref>
Immunostaining was performed as described previously [15], [16]. Antibodies used were: H3diK4 (clone RR302; Upstate), H3diK9 (kindly provided by T. Jenuwein), H3triK9 (kindly provided by T. Jenuwein), H4Ac (anti-acetyl-Histone H4; Upstate), ss1 integrin (P5D2) [43], H4monoK20 (ab9051; Abcam), H4diK20 (ab14092, Abcam), H4triK20 (ab9053; Abcam), Set8 (PR/SET07; Abgent), Ash-1 (ab4477; Abcam), tubulin (Sigma), Misu (NSun2) (EF1) [16], keratin 14 (MK14, Babco), keratin 10 (MK10, Covance), Ki67 (Novacastra), BrDU (Becton Dickinson) and Myc (N262, Santa Cruz).
###end p 66
###begin p 67
Images were acquired and expression levels were estimated using a Zeiss 510 confocal microscope. Approximately 30 optical sections of each epidermal sheet were captured with an increment of 1 microm. Scans are presented as z-projections, scanned from the dermal side towards the epidermal surface. The number of LRC was counted per hair follicle bulge and per optical field in the interfollicular epidermis (Zeiss 20/NA 0.75).
###end p 67
###begin title 68
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human keratinocyte culture, retroviral infection and Western blotting
###end title 68
###begin p 69
###xml 225 227 225 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 357 360 349 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;10</sup>
###xml 444 448 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Gandarillas1">[23]</xref>
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 267 271 <span type="species:ncbi:9913">calf</span>
###xml 506 510 <span type="species:ncbi:9913">calf</span>
Primary human keratinocytes were isolated from neonatal foreskin and cultured in the presence of a feeder layer of J2-3T3 cells in FAD medium (1 part Ham's F12 medium, 3 parts Dulbecco's modified Eagle's medium (DMEM), 1.8x10-4 M adenine) supplemented with 10% fetal calf serum (FCS) and a cocktail of 0.5 microg / ml hydrocortisone, 5 microg/ml insulin, 10-10 M cholera toxin and 10 ng/ml epidermal growth factor (EGF) as described previously [23]. J2-3T3 cells were cultured in DMEM containing 10% donor calf serum.
###end p 69
###begin p 70
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Morgenstern1">[44]</xref>
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Gandarillas1">[23]</xref>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Gandarillas1">[23]</xref>
Keratinocytes were infected with the following retroviral vectors: pBabe puro (empty vector) [44] and pBabeMycER [23]. Keratinocytes were infected by co-culture with retroviral producer cells as described previously and used within one or two passages after infection [23]. Activation of the steroid-inducible constructs was performed by adding 200 nM 4OHT (Sigma) to the culture medium.
###end p 70
###begin p 71
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000763-Frye1">[15]</xref>
Keratinocytes were solubilised in RIPA buffer, resolved by SDS-polyacrylamide gel electrophoresis and subjected to Western blotting as described previously [15].
###end p 71
###begin title 72
Supporting Information
###end title 72
###begin p 73
###xml 596 605 596 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g002">Figures 2</xref>
###xml 610 611 610 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000763-g003">3</xref>
Quantitation of immunofluorescence labelling in epidermal whole mounts. The fluorescence signal (y axes) along lines (white arrows; x axes) crossing representative regions of the bulge or interfollicular epidermis (IFE) double labelled for LRC (red) and histone modifications (green) is shown. Peaks of fluorescence correspond to nuclei. When the peaks of red and green coincide an LRC has a high level of the histone modification (asterisks), but when the red peak corresponds to a low level of green the LRC has a low level of the modification (circle). This is the basis for the histograms in Figures 2 and 3.
###end p 73
###begin p 74
(5.41 MB TIF)
###end p 74
###begin p 75
Click here for additional data file.
###end p 75
###begin p 76
We thank Dr. Salvador Aznar Benitah and Dr. Kristin Braun for stimulating discussions and practical help.
###end p 76
###begin title 77
References
###end title 77
###begin article-title 78
Translating the histone code.
###end article-title 78
###begin article-title 79
Epigenetics and cancer.
###end article-title 79
###begin article-title 80
Chromatin remodeling in neural development and plasticity.
###end article-title 80
###begin article-title 81
Stem cell self-renewal controlled by chromatin remodeling factors.
###end article-title 81
###begin article-title 82
Epigenetic alchemy for cell fate conversion.
###end article-title 82
###begin article-title 83
Histone hypomethylation is an indicator of epigenetic plasticity in quiescent lymphocytes.
###end article-title 83
###begin article-title 84
The role of histone modifications in epigenetic transitions during normal and perturbed development.
###end article-title 84
###begin article-title 85
Epithelial stem cells: a folliculocentric view.
###end article-title 85
###begin article-title 86
###xml 84 89 <span type="species:ncbi:9606">human</span>
The spatial relationship between stem cells and their progeny in the basal layer of human epidermis: a new view based on whole-mount labelling and lineage analysis.
###end article-title 86
###begin article-title 87
Epidermal stem cells: an update.
###end article-title 87
###begin article-title 88
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny.
###end article-title 88
###begin article-title 89
Deregulated expression of c-Myc depletes epidermal stem cells.
###end article-title 89
###begin article-title 90
Analysis of genomic targets reveals complex functions of MYC.
###end article-title 90
###begin article-title 91
The c-Myc target gene network.
###end article-title 91
###begin article-title 92
Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment.
###end article-title 92
###begin article-title 93
The RNA methyltransferase Misu (NSun2) mediates Myc-induced proliferation and is upregulated in tumors.
###end article-title 93
###begin article-title 94
Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1.
###end article-title 94
###begin article-title 95
Mechanism of transcriptional activation by the Myc oncoproteins.
###end article-title 95
###begin article-title 96
Myc influences global chromatin structure.
###end article-title 96
###begin article-title 97
###xml 79 84 <span type="species:ncbi:9606">human</span>
Role of melanoma chondroitin sulphate proteoglycan in patterning stem cells in human interfollicular epidermis.
###end article-title 97
###begin article-title 98
Identification and behavior of label-retaining cells in oral mucosa and skin.
###end article-title 98
###begin article-title 99
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
Manipulation of stem cell proliferation and lineage commitment: visualisation of label-retaining cells in wholemounts of mouse epidermis.
###end article-title 99
###begin article-title 100
###xml 34 39 <span type="species:ncbi:9606">human</span>
c-Myc promotes differentiation of human epidermal stem cells.
###end article-title 100
###begin article-title 101
MYC recruits the TIP60 histone acetyltransferase complex to chromatin.
###end article-title 101
###begin article-title 102
The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc.
###end article-title 102
###begin article-title 103
Histone H4-lysine 20 monomethylation is increased in promoter and coding regions of active genes and correlates with hyperacetylation.
###end article-title 103
###begin article-title 104
The reorganisation of constitutive heterochromatin in differentiating muscle requires HDAC activity.
###end article-title 104
###begin article-title 105
Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.
###end article-title 105
###begin article-title 106
Purification and functional characterization of SET8, a nucleosomal histone H4-lysine 20-specific methyltransferase.
###end article-title 106
###begin article-title 107
Specificity and mechanism of the histone methyltransferase Pr-Set7.
###end article-title 107
###begin article-title 108
###xml 27 37 <span type="species:ncbi:7227">Drosophila</span>
Histone methylation by the Drosophila epigenetic transcriptional regulator Ash1.
###end article-title 108
###begin article-title 109
Contribution of stem cells and differentiated cells to epidermal tumours.
###end article-title 109
###begin article-title 110
Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis.
###end article-title 110
###begin article-title 111
Distinct stem cell populations regenerate the follicle and interfollicular epidermis.
###end article-title 111
###begin article-title 112
Polycomb silencers control cell fate, development and cancer.
###end article-title 112
###begin article-title 113
###xml 23 28 <span type="species:ncbi:9606">human</span>
Genomic targets of the human c-Myc protein.
###end article-title 113
###begin article-title 114
Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation.
###end article-title 114
###begin article-title 115
###xml 59 64 <span type="species:ncbi:9606">human</span>
Histone H4 acetylation distinguishes coding regions of the human genome from heterochromatin in a differentiation-dependent but transcription-independent manner.
###end article-title 115
###begin article-title 116
A trans-tail histone code defined by monomethylated H4 Lys-20 and H3 Lys-9 demarcates distinct regions of silent chromatin.
###end article-title 116
###begin article-title 117
###xml 36 41 <span type="species:ncbi:9606">human</span>
Myc-binding-site recognition in the human genome is determined by chromatin context.
###end article-title 117
###begin article-title 118
Inhibition of histone deacetylation promotes abnormal epidermal differentiation and specifically suppresses the expression of the late differentiation marker profilaggrin.
###end article-title 118
###begin article-title 119
Chromatin-modulating agents as epigenetic anticancer drugs-'the die is cast'.
###end article-title 119
###begin article-title 120
###xml 14 19 <span type="species:ncbi:9606">human</span>
Regulation of human B-cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1).
###end article-title 120
###begin article-title 121
A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells.
###end article-title 121
###begin p 122
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 122
###begin p 123
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by funds from Cancer Research UK (FMW and MF), EuroStemCell (FMW), the Medical Research Council (AF) and the Wellcome Trust (FMW).
###end p 123

